Articles by Melanie Sena - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Melanie Sena

FDA Targets Illegal Online Pharmacies

May 27, 2014

FDA targets illegal online pharmacies that sell unapproved prescription drugs to US consumers.

Selexys Pharmaceuticals Signs CMO Agreement with Cytovance Biologics

May 22, 2014

Cytovance Biologics and Selexys Pharmaceuticals enter an agreement for development of clinical trial materials.

Kymab Receives $40 Million Investment From Gates Foundation and Wellcome Trust

May 22, 2014

Kymab receives $40 million investment for clinical development of antibody therapeutics.

FDA Approves Entyvio for Ulcerative Colitis and Crohn's Disease

May 21, 2014

DA approves Entyvio, an injection to treat adult patients with moderate to severe ulcerative colitis and Crohn's disease.

Shark Antibodies Inspire Optimization of Human Antibodies

May 20, 2014

The structural analysis of shark IgNAR antibodies reveals evolutionary principles of immunoglobulins.

FDA Issues Complete Response Letter for Novartis' RLX030

May 20, 2014

FDA issues complete response letter for Novartis' RLX030 for acute heart failure.

Meissner Begins Operations At New Headquarters

May 20, 2014

Meissner moves into its new headquarters in Camarillo, California.

Novartis Settles Patent Litigation Over Gleevec

May 20, 2014

Novartis settles its litigation with the US subsidiary of Sun Pharma regarding Gleevec.

SGS Announces Appointments at New Facility in California

May 19, 2014

SGS makes two senior appointments at its new GMP/GLP laboratory in Carson, California.

ADVERTISEMENT

ADVERTISEMENT

Click here